Medical Therapies for Heart Failure With Preserved Ejection Fraction (HFpEF) Review

The major findings of our study are: (i) p66ShcA was upregulated in hearts of patients with ischemic heart disease without heart failure, (ii) myocardial infarction transiently

demonstrated that circulating endothelin-1 concentrations were elevated in chronic heart failure in proportion to the severity of pulmonary hypertension 3 and associated with

38.7% of the HFmrEF patients transitioned (56.4% to HFpEF and 43.6% to HFrEF) with fewest deaths in the patients that transitioned to HFpEF (p 0.04), and fewest HF readmissions in

Reduced cardiovascular mortality 10 years after supplementation with selenium and coenzyme Q10 for four years: follow-up results of a prospective randomized double-blind

Median (and interquartile range) of income across education and age groups in patients hospitalized with an incident heart failure in Norway, 2000-2014: the

Tilsvarende brukes «hjertesvikt med redusert ejeksjonsfraksjon» (heart failure with reduced ejection fraction) om hjertesviktpasienter med nedsa ejeksjonsfraksjon, i stedet

I Valsartan Heart Failure Trial (ValHeFT) blir valsartan eller placebo gi til pasienter som har hjertesvikt og som allerede bruker konvertasehemmere (36).. Studien Candesartan in

Compared to women without hypertensive disorders of pregnancy (HDP), women with preeclampsia had two-fold risk of future heart failure. Risk of heart failure was not modified